The Company

FemPulse

FemPulse GmbH was founded in 2019 as a med-tech startup in Vienna and is the exclusive licensee of FemPulse Corp in the US, which is also a minority shareholder. FemPulse Corp holds a large number of international patents. Thanks to a bilateral cooperation agreement, FemPulse GmbH can access and develop the latest findings from the USA at any time.

FemPulse GmbH’s corporate objective is to develop an innovative device for the therapy of the “overactive female bladder”. The company will be active in the EU area. Once approval has been granted, which is expected in 2024, FemPulse GmbH will market the product on its own account, within the European regulatory framework, and provide the necessary distribution.

The med-tech start-up is currently supported and promoted by aws Seedfinancing (Austria Wirtschaftsservice) and the VBA – Gründerservice. Further potential fields of research are currently in the evaluation phase.

FemPulse and The Elegant Solution are trademarks of FemPulse LLC

Botox is a registered trademark of Allergan Inc. Other companies, products and magazines referenced on this website are registered or unregistered trademarks of their respective owners.

Important information: Medical devices are regulated by the responsible supervisory authority in each country. FemPulse devices have not yet been approved or released for sale in the EU and are currently only potentially available for controlled clinical investigations. The content of this website is intended for healthcare professionals only. All statements that refer to design intent must be checked for validity in the future.